POSTER SESSION I - STOWELL-ORBISON AWARDS COMPETITION
Monday, March 26, 2007   —  9:30 AM - 12:00 Noon
Convention Center, Exhibit Hall B - 1


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...

...then notice the 'Event Added' prompt
in the toolbar above as feedback:
 



GYNECOLOGIC PATHOLOGY



Poster#Title and AuthorsItinerary
Planner
119 Sampling of the Grossly Negative Omentum in Ovarian Neoplasms (853)
C Allen, SM Lele - University of Kentucky College of Medicine, Lexington, KY; University of Nebraska Medical Center, Omaha, NE
Add
120 Differential Expression of Matrix Metalloproteinases in Ovarian Carcinoma (867)
BD Bolton, S Bishu, J Symowicz, K Gleason, MS Stack, BP Adley - NU Feinberg School of Medicine, Chicago, IL
Add
121 High Grade Cervical Intraepithelial Neoplasia (CIN 2 & 3) Excised with Negative Margins by Loop Electrosurgical Excision Procedure: The Significance of Grade 1 CIN at the Margins of Excision (870)
G Cardoza-Favarato, O Fadare - Wilford Hall Medical Center, Lackland AFB, TX
Add
122 Immunohistochemical Comparison of Endometrioid Carcinomas of Ovary Versus Endometrium (875)
I Chebib, DN Ionescu, A Alkushi, AM Gown, CB Gilks - University of Calgary and Calgary Laboratory Services, Calgary, AB, Canada; BC Cancer Agency, Vancouver, BC, Canada; King Fahad National Guard Hospital, Riyadh, Saudi Arabia; PhenoPath Laboratories and IMPRIS, Seattle, WA; Vancouver General Hospital, Vancouver, BC, Canada
Add
123 Peritumoral Lymphatic Vessel Density as a Prognostic Marker in Endometrial Carcinoma (886)
KL Denning, JF Silverman, YL Liu, M Tung, RS Saad - Allegheny General Hospital, Pittsburgh, PA
Add
124 A Wide Spectrum of Serous Carcinomas Arise in Ovarian Serous Borderline Tumors: A Report of 25 Cases (887)
A Dionigi, E Oliva, AJ Iafrate, DA Bell - Massachusetts General Hospital, Boston, MA
Add
125 Immunohistochemical Comparison of Endocervical Adenocarcinomas and Endometrial Endometrioid Carcinomas (888)
B Djordjevic, D El Demellawy, W Chapman - University of Toronto, Toronto, ON, Canada
Add
126 MicroRNA Gene Expression Profiling in Human Ovarian and Primary Peritoneal Serous Carcinomas (897)
RJ Flavin, S O’Toole, P Smyth, A Laois, S Cahill, J Li, K Denning, C Martin, S Finn, B Shepherd, K Lao, O Sheils, JJ O’Leary - Trinity College, Dublin, Ireland; Applied Biosystems, Foster City, CA
Add
127 EGFR and HER2/neu Expression in Stage Matched Type 1 and Type 2 Endometrial Carcinoma (907)
V Gowda, S Logani - Emory University Hospital, Atlanta, GA
Add
128 Interobserver Variation in the Diagnosis of Ovarian Clear Cell Carcinoma and Mixed Ovarian Epithelial Carcinomas with a Clear Cell Component (910)
G Han, CB Gilks, S Leung, CA Ewanowich, JA Irving, TA Longacre, RA Soslow - Vancouver General Hospital, Vancouver, BC, Canada; Royal Alexandra Hospital, Edmonton, AB, Canada; Stanford University Medical Center, Stanford, CA; Memorial Sloan-Kettering Cancer Center, New York, NY
Add
129 Uterine Malignant Müllerian Mixed Tumor: A Morphologic and Immunohistochemical Study with Emphasis on the Diagnosis of Heterologous Rhabdomyosarcoma (912)
JA Harris, JK McKenney - University of Arkansas for Medical Sciences, Little Rock, AR
Add
130 Let-7 miRNAs Inhibit Leiomyoma Growth through down Regulation of HMGA2 (934)
J Laser, P Lee, K Mittal, JJ Wei - NYU Medical Center, New York, NY
Add
131 Endometrial Ablation for Dysfunctional Uterine Bleeding: Histologic Insights into Treatment Failures (943)
R Livengood, N Bailey, JE Coad - West Virginia University, Morgantown, WV
Add
132 Differential Immunoreactivity of p16 in Uterine Leiomyosarcomas and Benign Variants of Leiomyoma (944)
M Manduch, BR Gannon, TJ Childs - Kingston General Hospital, Queen’s University, Kingston, ON, Canada
Add
133 Where Is the High Grade Dysplasia Now? Impact of the Bethesda 2001 Classification and Liquid-Based Pap Tests on Cytohistologic Correlations (951)
MY Ngae, K Kjeldahl, SG Miller, DM McKeon, TM Ten Haken, HE Gulbahce, SE Pambuccian - University of Minnesota, Minneapolis, MN; University of Minnesota Medical Center-Fairview
Add
134 Multifocal Mucosal Hyperplasia of Fallopian Tube Is More Common with Ovarian Surface Epithelial Carcinomas and Borderline Tumors, and in BRCA Mutation Patients with No Evidence of Neoplasia (959)
R Pathi, MR Quddus, CJ Sung, MM Steinhoff, R Moore, F Liu, WD Lawrence - Women & Infants Hospital/Brown Medical School, Providence, RI
Add
135 Ovarian Borderline Mucinous Tumor of Endocervical Type: A Clinicopathologic Study of 78 Cases (962)
LE Posligua, MT Deavers, EG Silva, A Malpica - The University of Texas MD Anderson Cancer Center, Houston, TX
Add
136 Lymphatic Vessel Invasion in Ovarian Serous Tumors of Low Malignant Potential with Stromal Microinvasion: A Case Control Study (975)
AR Sangoi, JK McKenney, SS Dadras, TA Longacre - University of Arkansas Medical Sciences, Little Rock, AR; Stanford University, Stanford, CA
Add
137 Combined Transverse and Longitudinal Sectioning of Radical Hysterectomy Specimens Gives More Accurate Pathological Information for Invasive Cervical Cancer (982)
DE Song, JY Ro, KR Kim - University of Ulsan College of Medicine, Seoul, Republic of Korea; The Methodist Hospital, Weill Medical School, Cornell University, Houston, TX
Add
138 Correlation Study of Dysregulated miRNAs and Their Predicted Target Genes in Uterine Leiomyomas (1000)
H Ye, TS Wang, L Chiriboga, H Yee, K Mittal, P Soteropoulos, JJ Wei - New York University School of Medicine, New York, NY; New Jersey Public Health Research Institute, Newark, NJ
Add